D'Aversa F - Search Results

1

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver.

Lopetuso LR, Mocci G, Marzo M, D'Aversa F, Rapaccini GL, Guidi L, Armuzzi A, Gasbarrini A, Papa A. Lopetuso LR, et al. Int J Mol Sci. 2018 Jul 27;19(8):2199. doi: 10.3390/ijms19082199. Int J Mol Sci. 2018. PMID: 30060508 Free PMC article. Review.

2

Folate in gastrointestinal health and disease.

Ponziani FR, Cazzato IA, Danese S, Fagiuoli S, Gionchetti P, Annicchiarico BE, D'Aversa F, Gasbarrini A. Ponziani FR, et al. Eur Rev Med Pharmacol Sci. 2012 Mar;16(3):376-85. Eur Rev Med Pharmacol Sci. 2012. PMID: 22530356 Review.

3

What we should know about portal vein thrombosis in cirrhotic patients: a changing perspective.

Ponziani FR, Zocco MA, Garcovich M, D'Aversa F, Roccarina D, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2012 Sep 28;18(36):5014-20. doi: 10.3748/wjg.v18.i36.5014. World J Gastroenterol. 2012. PMID: 23049208 Free PMC article. Review.

4

Gut microbiota and metabolic syndrome.

D'Aversa F, Tortora A, Ianiro G, Ponziani FR, Annicchiarico BE, Gasbarrini A. D'Aversa F, et al. Intern Emerg Med. 2013 Apr;8 Suppl 1:S11-5. doi: 10.1007/s11739-013-0916-z. Intern Emerg Med. 2013. PMID: 23468402 Review.

5

Treatment of hepatitis C in compensated cirrhotic patients is equally effective before and after liver transplantation.

Ponziani FR, Annicchiarico EB, Siciliano M, D'Aversa F, Pompili M, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2013 Jun 7;19(21):3255-62. doi: 10.3748/wjg.v19.i21.3255. World J Gastroenterol. 2013. PMID: 23745027 Free PMC article.

6

Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

Ianiro G, Bruno G, Lopetuso L, Beghella FB, Laterza L, D'Aversa F, Gigante G, Cammarota G, Gasbarrini A. Ianiro G, et al. Curr Pharm Des. 2014;20(28):4565-9. doi: 10.2174/13816128113196660723. Curr Pharm Des. 2014. PMID: 24180411 Review.

7

Nutrients affecting gastric barrier.

Gasbarrini A, D'Aversa F, Di Rienzo T, Franceschi F. Gasbarrini A, et al. Dig Dis. 2014;32(3):243-8. doi: 10.1159/000357856. Epub 2014 Apr 10. Dig Dis. 2014. PMID: 24732190 Review.

8

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.

Ponziani FR, Gerardi V, Pecere S, D'Aversa F, Lopetuso L, Zocco MA, Pompili M, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2015 Nov 21;21(43):12322-33. doi: 10.3748/wjg.v21.i43.12322. World J Gastroenterol. 2015. PMID: 26604640 Free PMC article. Review.

9

[The relationship between gut microbiota and cardiovascular diseases].

Gerardi V, Del Zompo F, D'Aversa F, Gasbarrini A. Gerardi V, et al. G Ital Cardiol (Rome). 2016 Jan;17(1):11-4. doi: 10.1714/2140.23182. G Ital Cardiol (Rome). 2016. PMID: 26901254 Italian.

10

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation.

Ponziani FR, Zocco MA, D'Aversa F, Pompili M, Gasbarrini A. Ponziani FR, et al. World J Gastroenterol. 2017 Jul 7;23(25):4491-4499. doi: 10.3748/wjg.v23.i25.4491. World J Gastroenterol. 2017. PMID: 28740337 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page